Remote Therapeutic Monitoring in Rheumatic and Musculoskeletal Diseases: Opportunities and Implementation

Therapeutic Monitoring (RTM) is a new program in the United States that began 2022 allowing electronic patient-reported outcomes (ePRO) and other patient-generated data to be reviewed by clinical staff between visits so patients can receive attention as needed. Remote simultaneously enhances capacity generate prospective longitudinal may useful for secondary research purposes. As many governmental private insurance programs now provide reimbursement Monitoring, increasing numbers of rheumatologists incentivized this service their patient populations. Launched 2015, ArthritisPower® Research Registry associated mobile desktop application, registered with Food & Drug Administration (FDA) Class I medical device, enables track disease across dozens domains securely participate voluntary studies. ArthritisPower, partnership Illumination Health, has developed infrastructure workflow will help more closely patients’ activity flares, identify primary non-adherence, record changes key health (e.g. fatigue, pain, physical function, mental health) meet needs elements important care identified individual providers. Ultimately, approach use digital tools seeks improve rheumatic musculoskeletal diseases. This editorial review discusses evolution remote monitoring rheumatologic care, describes opportunities physician 2023, provides suggested order establish within rheumatology practices.